Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Amany A. Azouz, Doaa M. Abdel-Rahman & Basim Anwar Shehata Messiha. (2023) Balancing renal Ang-II/Ang-(1–7) by xanthenone; an ACE2 activator; contributes to the attenuation of Ang-II/p38 MAPK/NF-κB p65 and Bax/caspase-3 pathways in amphotericin B-induced nephrotoxicity in rats. Toxicology Mechanisms and Methods 33:6, pages 452-462.
Read now
Read now
Masato Tashiro, Yoko Obata, Takahiro Takazono, Yuki Ota, Tomotaro Wakamura, Yui Shiozawa, Ai Tsuyuki, Taiga Miyazaki, Tomoya Nishino & Koichi Izumikawa. (2022) Association between fluid infusions and the recovery from acute kidney injury in patients administered liposomal amphotericin B: a nationwide observational study. Renal Failure 44:1, pages 282-292.
Read now
Read now
Nahed Abdel-Haq, Stephanie M. Smith & Basim I. Asmar. (2022) Micafungin injection for the treatment of invasive candidiasis in pediatric patients under 4 months of age. Expert Review of Anti-infective Therapy 20:4, pages 493-505.
Read now
Read now
N. Basaran Mutlu-Agardan, Sukran Yilmaz, Fatma Kaynak Onurdag & Nevin Celebi. (2021) Development of effective AmB/AmB–αCD complex double loaded liposomes using a factorial design for systemic fungal infection treatment. Journal of Liposome Research 31:2, pages 177-188.
Read now
Read now
Yidong Yu, Krystyna Albrecht, Jürgen Groll & Andreas Beilhack. (2020) Innovative therapies for invasive fungal infections in preclinical and clinical development. Expert Opinion on Investigational Drugs 29:9, pages 961-971.
Read now
Read now
Savvas G. Papachristou, Elias Iosifidis, Nikolaos V. Sipsas, Maria N. Gamaletsou, Thomas J. Walsh & Emmanuel Roilides. (2020) Management of osteoarticular fungal infections in the setting of immunodeficiency. Expert Review of Anti-infective Therapy 18:5, pages 461-474.
Read now
Read now
Diego R. Falci, Franciane B. da Rosa & Alessandro C. Pasqualotto. (2015) Hematological toxicities associated with amphotericin B formulations. Leukemia & Lymphoma 56:10, pages 2889-2894.
Read now
Read now
Elisabeth Maurer, Niall Browne, Carla Surlis, Emina Jukic, Patrizia Moser, Kevin Kavanagh, Cornelia Lass-Flörl & Ulrike Binder. (2015) Galleria mellonella as a host model to study Aspergillus terreus virulence and amphotericin B resistance. Virulence 6:6, pages 591-598.
Read now
Read now
Hyera Kang, Yasuhiro Takahashi, Kunihiro Nishimura, Yuka Yamagishi, Hiroshige Mikamo & Hirohiko Kakizaki. (2015) Invasive Fungal Sinusitis Involving the Orbital Apex in a Patient with Chronic Renal Failure. Neuro-Ophthalmology 39:4, pages 183-186.
Read now
Read now
Theodouli Stergiopoulou & Thomas J Walsh. (2015) Clinical pharmacology of antifungal agents to overcome drug resistance in pediatric patients. Expert Opinion on Pharmacotherapy 16:2, pages 213-226.
Read now
Read now
Articles from other publishers (41)
Kashish MadaanVinay Kumar Bari. (2023) Emerging Role of Sphingolipids in Amphotericin B Drug Resistance. Microbial Drug Resistance 29:8, pages 319-332.
Crossref
Crossref
Erfan Abdollahizad, Simin Dadashzadeh, Shima Bahri, Zahra Abbasian & Elham Rezaee. (2023) Amphotericin B Pharmacokinetics: Inter-strain Differences in Rats Following Intravenous Administration of the Most Commonly Marketed Formulations of the Drug. Iranian Journal of Pharmaceutical Research 22:1.
Crossref
Crossref
Maria N. Gamaletsou, Blandine Rammaert, Barry Brause, Marimelle A. Bueno, Sanjeet S. Dadwal, Michael W. Henry, Aspasia Katragkou, Dimitrios P. Kontoyiannis, Matthew W. McCarthy, Andy O. Miller, Brad Moriyama, Zoi Dorothea Pana, Ruta Petraitiene, Vidmantas Petraitis, Emmanuel Roilides, Jean-Pierre Sarkis, Maria Simitsopoulou, Nikolaos V. Sipsas, Saad J. Taj-Aldeen, Valérie Zeller, Olivier Lortholary & Thomas J. Walsh. (2022) Osteoarticular Mycoses. Clinical Microbiology Reviews 35:4.
Crossref
Crossref
Shobha Kumari, Vikash Kumar, Ritesh Kumar Tiwari, Vidyanand Ravidas, Krishna Pandey & Ashish Kumar. (2022) Amphotericin B: A drug of choice for Visceral Leishmaniasis. Acta Tropica 235, pages 106661.
Crossref
Crossref
Shamanth A. Shankarnarayan, Joshua D. Guthrie & Daniel A. Charlebois. 2022. The Global Antimicrobial Resistance Epidemic - Innovative Approaches and Cutting-Edge Solutions. The Global Antimicrobial Resistance Epidemic - Innovative Approaches and Cutting-Edge Solutions.
R. Silva-Carvalho, T. Leão, A. I. Bourbon, C. Gonçalves, L. M. Pastrana, P. Parpot, I. Amorim, A. M. Tomás & F. M. Gama. (2022) Hyaluronic acid–amphotericin B nanocomplexes: a promising anti-leishmanial drug delivery system. Biomaterials Science 10:8, pages 1952-1967.
Crossref
Crossref
N. Haddad, M. Bechwati, H. Ayoub, R.M. Zeenny & S.S. Kanj. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
322
342
.
Yuki Ota, Yoko Obata, Takahiro Takazono, Masato Tashiro, Tomotaro Wakamura, Akinori Takahashi, Yui Shiozawa, Taiga Miyazaki, Tomoya Nishino & Koichi Izumikawa. (2021) Association between potassium supplementation and the occurrence of acute kidney injury in patients with hypokalemia administered liposomal amphotericin B: a nationwide observational study. BMC Nephrology 22:1.
Crossref
Crossref
Ellis Tobin & Sara Brenner. (2021) Nanotechnology Fundamentals Applied to Clinical Infectious Diseases and Public Health. Open Forum Infectious Diseases 8:12.
Crossref
Crossref
Borja Suberviola. (2021) Seguridad clínica de la anfotericina B liposomal. Revista Iberoamericana de Micología 38:2, pages 56-60.
Crossref
Crossref
Yoko Obata, Takahiro Takazono, Masato Tashiro, Yuki Ota, Tomotaro Wakamura, Akinori Takahashi, Kumiko Sato, Taiga Miyazaki, Tomoya Nishino & Koichi Izumikawa. (2020) The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study. Clinical and Experimental Nephrology 25:3, pages 279-287.
Crossref
Crossref
Irene García-Barbazán & Óscar Zaragoza. 2021. Encyclopedia of Mycology. Encyclopedia of Mycology
421
426
.
Yayuan Liu, Zihan Mei, Ling Mei, Jie Tang, Wenmin Yuan, Santhanakrishnan Srinivasan, Rose Ackermann & Anna S. Schwendeman. (2020) Analytical method development and comparability study for AmBisome® and generic Amphotericin B liposomal products. European Journal of Pharmaceutics and Biopharmaceutics 157, pages 241-249.
Crossref
Crossref
Takahiro Takazono, Masato Tashiro, Yuki Ota, Yoko Obata, Tomotaro Wakamura, Taiga Miyazaki, Tomoya Nishino & Koichi Izumikawa. (2020) Factor analysis of acute kidney injury in patients administered liposomal amphotericin B in a real-world clinical setting in Japan. Scientific Reports 10:1.
Crossref
Crossref
María Álvarez-Bardón, Yolanda Pérez-Pertejo, César Ordóñez, Daniel Sepúlveda-Crespo, Nestor M. Carballeira, Babu L. Tekwani, Sankaranarayanan Murugesan, Maria Martinez-Valladares, Carlos García-Estrada, Rosa M. Reguera & Rafael Balaña-Fouce. (2020) Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria. Marine Drugs 18:4, pages 187.
Crossref
Crossref
Faustino & Pinheiro. (2020) Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy. Pharmaceutics 12:1, pages 29.
Crossref
Crossref
Marco Vinícius Chaud, Alessandra Cândida Rios, Carolina Alves dos Santos, Cecilia Torqueti de Barros, Juliana Ferreira de Souza & Thais Francine Ribeiro Alves. 2020. Nanomycotoxicology. Nanomycotoxicology
449
480
.
Houdaii H. El-Houssaini, Omnia M. Elnabawy, Hebatallah A. Nasser & Walid F. Elkhatib. (2019) Influence of subinhibitory antifungal concentrations on extracellular hydrolases and biofilm production by Candida albicans recovered from Egyptian patients. BMC Infectious Diseases 19:1.
Crossref
Crossref
László Dézsi, Tamás Mészáros, Erik Őrfi, Tamás Fülöp, Mark Hennies, László Rosivall, Péter Hamar, János Szebeni & Gábor Szénási. (2019) Complement Activation-Related Pathophysiological Changes in Anesthetized Rats: Activator-Dependent Variations of Symptoms and Mediators of Pseudoallergy. Molecules 24:18, pages 3283.
Crossref
Crossref
Rosa M. Reguera, Yolanda Pérez-Pertejo, Camino Gutiérrez-Corbo, Bárbara Domínguez-Asenjo, César Ordóñez, Carlos García-Estrada, María Martínez-Valladares & Rafael Balaña-Fouce. (2019) Current and promising novel drug candidates against visceral leishmaniasis. Pure and Applied Chemistry 91:8, pages 1385-1404.
Crossref
Crossref
Thomas J Walsh, Russell E Lewis & Jill Adler-Moore. (2019) Pharmacology of Liposomal Amphotericin B: An Introduction to Preclinical and Clinical Advances for Treatment of Life-threatening Invasive Fungal Infections. Clinical Infectious Diseases 68:Supplement_4, pages S241-S243.
Crossref
Crossref
Andreas H Groll, Bart J A Rijnders, Thomas J Walsh, Jill Adler-Moore, Russell E Lewis & Roger J M Brüggemann. (2019) Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B. Clinical Infectious Diseases 68:Supplement_4, pages S260-S274.
Crossref
Crossref
Jill Adler-Moore, Russell E Lewis, Roger J M Brüggemann, Bart J A Rijnders, Andreas H Groll & Thomas J Walsh. (2019) Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B. Clinical Infectious Diseases 68:Supplement_4, pages S244-S259.
Crossref
Crossref
Manasvini Bhatt, Manish Soneja, Farhan Fazal, Surabhi Vyas, Prabhat Kumar, Pankaj Jorwal, Upendra Raj, Janya Sachdev, Gagandeep Singh, Immaculata Xess, Shah Alam & Ashutosh Biswas. (2018) Two cases of Osteoarticular Mucor menace: A diagnostic and management conundrum. Drug Discoveries & Therapeutics 12:6, pages 374-378.
Crossref
Crossref
Nikolaos Spernovasilis & Diamantis Kofteridis. (2018) Pre-Existing Liver Disease and Toxicity of Antifungals. Journal of Fungi 4:4, pages 133.
Crossref
Crossref
Daniel K. Benjamin, David A. Kaufman, William W. Hope, P. Brian Smith, Antonio Arrieta, Paolo Manzoni, Laura L. Kovanda, Christopher Lademacher, Brigit Isaacson, Deborah Jednachowski, Chunzhang Wu, Atsunori Kaibara & Thomas J. Walsh. (2018) A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis. Pediatric Infectious Disease Journal 37:10, pages 992-998.
Crossref
Crossref
B. G. J. Dekkers, A. Veringa, D. J. E. Marriott, J. M. Boonstra, K. C. M. van der Elst, F. F. Doukas, A. J. McLachlan & Jan-Willem C. Alffenaar. (2018) Invasive Candidiasis in the Elderly: Considerations for Drug Therapy. Drugs & Aging 35:9, pages 781-789.
Crossref
Crossref
Yaolin Chen, Jaideep Mallick, Alaa Maqnas, Yuan Sun, Baharul I. Choudhury, Pierre Côte, Lan Yan, Ting-jun-hong Ni, Yan Li, Dazhi Zhang, Roberto Rodríguez-Ortiz, Quan-zhen Lv, Yuan-ying Jiang & Malcolm Whiteway. (2018) Chemogenomic Profiling of the Fungal Pathogen Candida albicans. Antimicrobial Agents and Chemotherapy 62:2.
Crossref
Crossref
Dnyaneshwar D. Athavale, Robin Jones, Brett A. O’Donnell, Martin Forer & Nigel Biggs. (2017) Non-Exenteration Management of Sino-Orbital Fungal Disease. Ophthalmic Plastic & Reconstructive Surgery 33:6, pages 426-429.
Crossref
Crossref
Nita L. Seibel, Aziza T. Shad, Ihor Bekersky, Andreas H. Groll, Corina Gonzalez, Lauren V. Wood, Paul Jarosinski, Donald Buell, William W. Hope & Thomas J. Walsh. (2017) Safety, Tolerability, and Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Pediatric Patients. Antimicrobial Agents and Chemotherapy 61:2.
Crossref
Crossref
Shmuel Shoham, Andreas H. Groll, Vidmantas Petraitis & Thomas J. Walsh. 2017. Infectious Diseases. Infectious Diseases
1333
1344.e4
.
Matthew McCarthy, Elizabeth M. O’Shaughnessy & Thomas J. Walsh. 2017. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
387
395
.
Sarah Kagan, Diana E. Ickowicz, Abraham J. Domb, Arie Dagan & Itzhack Polacheck. (2016) Unique aggregation of conjugated amphotericin B and its interaction with lipid membranes. Medical Mycology, pages myw099.
Crossref
Crossref
Susan Meiring, Melony Fortuin-de Smidt, Ranmini Kularatne, Halima Dawood & Nelesh P. Govender. (2016) Prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South Africa. PLOS Neglected Tropical Diseases 10:7, pages e0004865.
Crossref
Crossref
Jill P Adler-Moore, Jean-Pierre Gangneux & Peter G Pappas. (2016) Comparison between liposomal formulations of amphotericin B. Medical Mycology 54:3, pages 223-231.
Crossref
Crossref
Neil R. H. Stone, Tihana Bicanic, Rahuman Salim & William Hope. (2016) Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions. Drugs 76:4, pages 485-500.
Crossref
Crossref
John D. Cleary & Kayla R. Stover. (2015) Antifungal-Associated Drug-Induced Cardiac Disease. Clinical Infectious Diseases 61:suppl_6, pages S662-S668.
Crossref
Crossref
Nicole M. Bohm, Katherine C. Hoover, Amy E. Wahlquist, Yusheng Zhu & Juan Carlos Q. Velez. (2015) Case-Control Study and Case Series of Pseudohyperphosphatemia during Exposure to Liposomal Amphotericin B. Antimicrobial Agents and Chemotherapy 59:11, pages 6816-6823.
Crossref
Crossref
Zaid Al-Nakeeb, Vidmantas Petraitis, Joanne Goodwin, Ruta Petraitiene, Thomas J. Walsh & William W. Hope. (2015) Pharmacodynamics of Amphotericin B Deoxycholate, Amphotericin B Lipid Complex, and Liposomal Amphotericin B against Aspergillus fumigatus. Antimicrobial Agents and Chemotherapy 59:5, pages 2735-2745.
Crossref
Crossref
Allison J. Stewart & Rosemary S. Cuming. (2015) Update on Fungal Respiratory Disease in Horses. Veterinary Clinics of North America: Equine Practice 31:1, pages 43-62.
Crossref
Crossref
B. Eleazar Cohen. (2014) Functional Linkage between Genes That Regulate Osmotic Stress Responses and Multidrug Resistance Transporters: Challenges and Opportunities for Antibiotic Discovery. Antimicrobial Agents and Chemotherapy 58:2, pages 640-646.
Crossref
Crossref